A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humans

被引:9
|
作者
Yatham, LN
Steiner, M
Liddle, PF
Shiah, IS
Lam, RW
Zis, AP
Coote, M
机构
[1] Univ British Columbia, Div Mood Disorders, Clin Res Unit, Vancouver, BC V6T 2A1, Canada
[2] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada
[3] Univ British Columbia, Dept Psychiat, Div Schizophrenia, Vancouver, BC, Canada
[4] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Psychiat, Taipei, Taiwan
基金
英国医学研究理事会;
关键词
5-HT2; receptor; platelet; brain; PET; setoperone; LSD binding;
D O I
10.1007/s002130000522
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Platelets share many properties with brain serotonergic neurons such as active 5-hydroxytryptamine (5-HT) transport, 5-HT2 receptors, and mitochondrial monoamine oxidase. Objectives. We measured brain 5-HT2 receptors and platelet 5-HT2 receptors in healthy volunteers to determine if there was any correlation between the two measures. Methods: Ten healthy volunteers with no lifetime history of psychiatric illness or family history in first-degree relatives were recruited, 5-HT2 receptor binding was determined for each subject with positron emission tomography and [F-18]setoperone scan in the brain and with H-3-LSD binding in platelets. Results. We found no significant correlation between 5-HT2 binding potential (BP) in platelets (B-max/K-d) and a semiquantitative estimate of 5-HT2 BP in frontal, parietal, and temporal cortical regions. SPM voxel based analysis also showed no significant correlation between the 5-HT2 BP in platelets and in the brains of the study subjects. Conclusions: Brain 5-HT2 receptor binding was not significantly correlated to platelet 3H-LSD binding in healthy subjects. This raises questions about the validity of generalizing findings from platelet studies to 5-HT neurons in the brain.
引用
收藏
页码:424 / 427
页数:4
相关论文
共 50 条
  • [21] A newly synthesized 5-HT2 receptor antagonist, AT-1015, slowly dissociates from 5-HT2 receptors
    Rashid, M
    Nagatomo, T
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 210P - 210P
  • [22] VASCULAR SEROTONIN RECEPTORS CORRELATION WITH 5-HT1 AND 5-HT2 BINDING-SITES
    PEROUTKA, SJ
    BIOCHEMICAL PHARMACOLOGY, 1984, 33 (15) : 2349 - 2353
  • [23] KETANSERIN - A SELECTIVE ANTAGONIST OF 5-HT2 SEROTONINERGIC RECEPTORS
    VANNUETEN, JM
    LEYSEN, JE
    SCHUURKES, JAJ
    VANHOUTTE, PM
    LANCET, 1983, 1 (8319): : 297 - 298
  • [24] Effect of electroconvulsive therapy on brain 5-HT2 receptors in major depression
    Yatham, Lakshmi N.
    Liddle, Peter F.
    Lam, Raymond W.
    Zis, Athanasios P.
    Stoessl, A. Jon
    Sossi, Vesna
    Adam, Michael J.
    Ruth, Thomas J.
    BRITISH JOURNAL OF PSYCHIATRY, 2010, 196 (06) : 474 - 479
  • [25] INVOLVEMENT OF SEROTONERGIC RECEPTORS(5-HT2) IN GASTROINTESTINAL MOTILITY
    DHASMANA, KM
    BANERJEE, AK
    ZHU, YN
    ERDMANN, W
    FASEB JOURNAL, 1991, 5 (05): : A1060 - A1060
  • [26] 5-HT RECEPTORS ON IDENTIFIED LYMNAEA NEURONS IN CULTURE - PHARMACOLOGICAL CHARACTERIZATION OF 5-HT2 RECEPTORS
    WALCOURTAMBAKEDEREMO, A
    WINLOW, W
    GENERAL PHARMACOLOGY, 1994, 25 (06): : 1079 - 1092
  • [27] Evidence that 5-HT2 receptor agonist induced inhibtion of 5-HT cell firing is mediated by central and not peripheral 5-HT2 receptors
    Boothman, LJ
    Allers, KA
    Rasmussen, K
    Sharp, T
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U2 - U2
  • [28] INVIVO KINETIC MODELING OF SEROTONIN (5-HT2) RECEPTORS
    SKINNER, MH
    WONG, YWJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 190 - 190
  • [29] Atypical Antipsychotics and Inverse Agonism at 5-HT2 Receptors
    Sullivan, Laura C.
    Clarke, William P.
    Berg, Kelly A.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (26) : 3732 - 3738
  • [30] PHARMACOKINETIC MODELING OF CENTRAL SEROTONIN (5-HT2) RECEPTORS
    SKINNER, MH
    WONG, YWJ
    FANGON, NB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (02) : 177 - 177